These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28321975)

  • 1. The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study.
    Shemesh E; Bucuvalas JC; Anand R; Mazariegos GV; Alonso EM; Venick RS; Reyes-Mugica M; Annunziato RA; Shneider BL
    Am J Transplant; 2017 Oct; 17(10):2668-2678. PubMed ID: 28321975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients.
    Christina S; Annunziato RA; Schiano TD; Anand R; Vaidya S; Chuang K; Zack Y; Florman S; Shneider BL; Shemesh E
    Liver Transpl; 2014 Oct; 20(10):1168-77. PubMed ID: 24931127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients.
    Killian MO; Little CW; Mayewski SE
    Clin Transplant; 2024 Oct; 38(10):e15442. PubMed ID: 39385672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Neighborhood-level Socioeconomic Deprivation and the Medication Level Variability Index for Children Following Liver Transplantation.
    Wadhwani SI; Bucuvalas JC; Brokamp C; Anand R; Gupta A; Taylor S; Shemesh E; Beck AF
    Transplantation; 2020 Nov; 104(11):2346-2353. PubMed ID: 32032293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability index of tacrolimus serum levels in pediatric liver transplant recipients younger than 12 years: Non-adherence or risk of non-adherence?
    de Oliveira JTP; Kieling CO; da Silva AB; Stefani J; Witkowski MC; Smidt CR; Mariano da Rocha CR; Hirakata VN; Grossini MDG; Zanotelli ML; Gonçalves Vieira SM
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 29034612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
    Venkat VL; Nick TG; Wang Y; Bucuvalas JC
    Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Medication Level Variability Index (MLVI) as a potential predictive biomarker of graft-versus-host disease in pediatric hematopoietic stem cell transplant patients.
    Skeens MA; Dietrich MS; Ryan-Wenger N; Gilmer MJ; Mulvaney SA; Akard TF
    Pediatr Transplant; 2019 Aug; 23(5):e13451. PubMed ID: 31066981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Management Measurement and Prediction of Clinical Outcomes in Pediatric Transplant.
    Annunziato RA; Bucuvalas JC; Yin W; Arnand R; Alonso EM; Mazariegos GV; Venick RS; Stuber ML; Shneider BL; Shemesh E
    J Pediatr; 2018 Feb; 193():128-133.e2. PubMed ID: 29162346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic Factors, Medication Adherence, and Post-transplant Health Outcomes: A Longitudinal Multilevel Modeling Approach.
    Killian MO; Little CW; Howry SK; Watkivs M; Triplett KN; Desai DM
    J Clin Psychol Med Settings; 2024 Mar; 31(1):163-173. PubMed ID: 37589865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of a Pre-Transplant Psychosocial Evaluation in Predicting Post-Liver Transplant Outcomes.
    Becker JH; Shemesh E; Shenoy A; Posillico A; Knight CS; Kim SK; Florman SS; Schiano T; Annunziato RA
    Prog Transplant; 2021 Mar; 31(1):4-12. PubMed ID: 33272096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence in pediatric and adolescent liver transplant recipients.
    Shemesh E; Shneider BL; Savitzky JK; Arnott L; Gondolesi GE; Krieger NR; Kerkar N; Magid MS; Stuber ML; Schmeidler J; Yehuda R; Emre S
    Pediatrics; 2004 Apr; 113(4):825-32. PubMed ID: 15060234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruiting a representative sample in adherence research-The MALT multisite prospective cohort study experience.
    Shemesh E; Mitchell J; Neighbors K; Feist S; Hawkins A; Brown A; Wanrong Y; Anand R; Stuber ML; Annunziato RA
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 28984072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients.
    Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA
    Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.
    Pollock-Barziv SM; Finkelstein Y; Manlhiot C; Dipchand AI; Hebert D; Ng VL; Solomon M; McCrindle BW; Grant D
    Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of once-daily LCP-Tacrolimus with adolescent and young adult solid organ transplant recipients.
    Householder S; Ramakrishnan A; Chen JK; Gorsch L; Tsapepas D; Lobritto S; Rundle A; Vittorio JM
    Pediatr Transplant; 2024 Jun; 28(4):e14777. PubMed ID: 38702932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-adherence and graft failure in adult liver transplant recipients.
    Lieber SR; Volk ML
    Dig Dis Sci; 2013 Mar; 58(3):824-34. PubMed ID: 23053889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote intervention engagement and outcomes in the Clinical Trials in Organ Transplantation in Children consortium multisite trial.
    Duncan-Park S; Dunphy C; Becker J; D'Urso C; Annunziato R; Blatter J; Conrad C; Goldfarb SB; Hayes D; Melicoff E; Schecter M; Visner G; Armstrong B; Chin H; Kesler K; Williams NM; Odim JN; Sweet SC; Danziger-Isakov L; Shemesh E
    Am J Transplant; 2021 Sep; 21(9):3112-3122. PubMed ID: 33752251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of psychosocial factors on medication level variability index and outcomes in pediatric liver transplant recipients.
    Sakhuja S; Himes R; Carreker C; Guffey D; Beer S; Amin M; Hiremath G; Mysore K
    Pediatr Transplant; 2023 Feb; 27(1):e14425. PubMed ID: 36325588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort.
    Shemesh E; Duncan S; Anand R; Shneider BL; Alonso EM; Mazariegos GV; Venick RS; Annunziato RA; Bucuvalas JC
    Liver Transpl; 2018 Jan; 24(1):80-88. PubMed ID: 28779546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to Research Determination of Late Acute Cellular Rejection in Pediatric Liver Transplant Recipients.
    Mazariegos GV; Shneider BL; Shemesh E; Schady D; Melin-Aldana H; Cho SJ; Anand R; Erinjeri J; Annunziato R; Reyes-Mugica M
    Liver Transpl; 2021 Jan; 27(1):106-115. PubMed ID: 32978871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.